Douglas Tsao analyst

Currently out of the existing stock ratings of Douglas Tsao, 292 are a BUY (80.44%), 3 are a SELL (0.83%), 68 are a HOLD (18.73%).

Douglas Tsao

Work Performance Price Targets & Ratings Chart

Analyst Douglas Tsao works with a stock forecast success ratio of 43.69% fulfilled within 179.95 days on average. Previously, Douglas Tsao worked at HC WAINWRIGHT.

Douglas Tsao’s has documented 697 price targets and ratings displayed on 42 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on OTLK, OUTLOOK THERAPEUTICS INC at 17-May-2024.

Wall Street Analyst Douglas Tsao

Analyst best performing recommendations are on PRAX (PRAXIS PRECISION MEDICINES ).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 10/26/2017. The price target of $50 was fulfilled within 1 day with a profit of $4.97 (9.04%) receiving and performance score of 90.41.

Average potential price target upside

CHMA Chiasma MYL Viatris JAZZ Jazz Pharmaceuticals PLC MNK Mallinckrodt plc PCRX Pacira Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR AGN Allergan plc ALKS Alkermes Plc CERE Cerevel Therapeutics Holdings CHRS Coherus BioSciences CRL Charles River Laboratories CRNX Crinetics Pharmaceuticals ENDP Endo International PLC EOLS Evolus IMVT Immunovant  MNTA Momenta Pharmaceuticals OSMT Osmotica Pharmaceuticals plc PRAX Praxis Precision Medicines  PRGO Perrigo Company PLC PTGX Protagonist Therapeutics RDUS Schnitzer Steel Industries RVNC Revance The SAGE Sage Therapeutic ROIV Roivant Sciences Ltd TBPH Theravance Biopharma TRVN Trevena TXMD TherapeuticsMD ARGX argenx NV ADR AMYT Amryt Pharma Holdings Ltd DARE Dare Bioscience APLS Apellis Pharmaceuticals CABA Cabaletta Bio ELYM Eliem Therapeutics EVO Evotec SE ADR NERV Minerva Neurosciences OTLK OUTLOOK THERAPEUTICS INC RVLP RVL Pharmaceuticals PLC RZLT Rezolute VRDN Viridian Therapeutics MRNS Marinus Pharmaceuticals SCPH Scpharmaceuticals AMAG AMAG Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5

$1.24 (32.98%)

18

3 years 12 days ago

0/6 (0%)

$1.02 (25.63%)

Buy

12

$8.24 (219.15%)

10

3 years 2 months 16 days ago

2/6 (33.33%)

$8.01 (200.75%)

651

Buy

15

$11.24 (298.94%)

19

3 years 4 months 7 days ago

0/9 (0%)

$10.93 (268.55%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Douglas Tsao is most bullish on?

Potential upside of $82.19 has been obtained for ARGX (ARGENX NV ADR)

Which stock is Douglas Tsao is most reserved on?

Potential downside of $2.9 has been obtained for CERE (CEREVEL THERAPEUTICS HOLDINGS)

What Year was the first public recommendation made by Douglas Tsao?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?